The ICR and The Royal Marsden together run a world-leading programme of clinical trials. We have developed innovative new drugs and led major trials demonstrating the effectiveness of precision radiotherapy.
But there remains an urgent need to develop better treatments for patients. Some cancers remain very hard to treat, as do most cancers once they have begun to spread round the body. And as we get better at treating cancer, more patients are living with the disease long term and often coping with serious side-effects from treatment.
We need more effective personalised therapies for cancer, with less severe side-effects than standard treatments. To do this, we must drive further innovations in the design of clinical trials and take new discoveries into the clinic more quickly and more smartly.